Azelis expands pharmaceutical offerings with Clariant
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
Tislelizumab is now approved in nine indications in China
Successfully removed peanut from the child’s left lung through bronchoscopy
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Avacc 3 has significant advantages over existing whooping cough vaccines
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Subscribe To Our Newsletter & Stay Updated